The fabricated nanoformulation (BVZ-NLC-DTX) selectively induced cell death by apoptosis in vascular endothelial growth factor (VEGF)-overexpressing GBM cells (U-87 MG and A172), but not in peripheral blood mononuclear cells. Here, VEGFA is linked to glioblastoma.